RightFit
Not yet recruitingNot applicable

RCT of HeartBot in Women

Efficacy of the Artificial Intelligence HeartBot II in Increasing Awareness and Knowledge of Heart Attack in Women: Study Protocol for a Randomized Controlled Trial With a Waitlist Control

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
25 Years and older
Sex
Female only
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will be asked to complete an online screening and baseline survey at the start of the study, as well as two follow-up surveys at 12 weeks and 24 weeks."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This online study tests whether HeartBot II, an app with an artificial intelligence (AI) chatbot, helps women learn about heart attacks in women. It is for women age 25 or older who live in the US and are University of California, San Francisco Health patients. By chance, participants will start the program right away or wait 12 weeks.

The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help improve women's awareness and knowledge of heart attacks in women. This is an online study with about 200 women taking part. Participants will be randomly assigned (by chance) to one of two groups: an intervention group or a wait-list control group. Participants in the intervention group will begin using the HeartBot II program right away. Participants in the wait-list control group will wait 12 weeks before starting the HeartBot II program. The HeartBot II program includes four short modules. In each module, participants will interact with a chatbot and spend about 10 to 15 minutes completing the content. Participants will be asked to complete an online screening and baseline survey at the start of the study, as well as two follow-up surveys at 12 weeks and 24 weeks.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are a woman.
  • Are age 25 or older.
  • Live in the US.
  • Are a University of California, San Francisco Health patient.
  • Have a smartphone with a data plan or Wi-Fi access.

Who can't join

  • Identify as male.
  • Report having problems with memory or thinking.
  • Have a history of heart disease or stroke.
  • Are a healthcare professional or are training to become one.
  • Work in the healthcare field.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Women * 25 years or older * Living in the US * University of California, San Francisco Health patient * Possessing a smartphone with a data plan or Wi-Fi access Exclusion Criteria: * Individuals who identify as male * Having self-reported cognitive impairment * Having history of heart disease or stroke * Healthcare professional/trainee * Working in the healthcare field

Study sites (1)

CA